Cyclodiode laser therapy for painful, blind glaucomatous eyes.
OBJECTIVE
To determine the ability of cyclodiode laser treatment to relieve discomfort in painful blind glaucomatous eyes.


METHODS
30 eyes underwent cyclodiode to reduce intraocular pressure (IOP) and relieve pain. Patients graded their pre-cyclodiode and post-cyclodiode pain.


RESULTS
After a minimum follow up of 6 months, a single cyclodiode treatment lowered mean IOP from 51 mm Hg (95% CI plus or minus 3.7 mm Hg) to 26 mm Hg (95% CI plus or minus 5.8 mm Hg) providing pain relief in 73.3% (22/30). After retreatment of six eyes, mean IOP was reduced to 22 (95% CI plus or minus 5.3) mm Hg and pain relief was obtained in 96.7% (29/30). For eyes achieving pain relief after one treatment, IOP was reduced by >30% in 81.0% (17/21). For eyes not achieving pain relief after one treatment, IOP was reduced by >30% in only 22.2% (2/9) (p=0.0042, Fisher's exact test).


CONCLUSIONS
Cyclodiode was highly successful in providing pain relief in painful blind hypertensive glaucomatous eyes. The best predictor of successful pain relief was IOP reduction of > 30% from baseline.
K R
KR
Martin
D C
DC
Broadway
D000368:Aged; D001766:Blindness / Q000209:etiology / Q000601:surgery*; D016001:Confidence Intervals; D005901:Glaucoma / Q000150:complications / Q000601:surgery*; D006801:Humans; D053685:Laser Therapy / Q000379:methods*; D016014:Linear Models; D008137:Longitudinal Studies; D010146:Pain / Q000209:etiology / Q000601:surgery*; D010147:Pain Measurement; D011183:Postoperative Complications; D011446:Prospective Studies; D014065:Tonometry, Ocular; D016896:Treatment Outcome